Skip to main content
. Author manuscript; available in PMC: 2013 Nov 22.
Published in final edited form as: Cancer Prev Res (Phila). 2011 Mar 23;4(5):10.1158/1940-6207.CAPR-10-0329. doi: 10.1158/1940-6207.CAPR-10-0329

Table 2.

Means, differences, and standard deviations of hormonal network biomarkers (μmol/L) for the tomato arm of the intervention (n=60)

Biomarker Week 2 Week 12 mean (sd) Difference P§
IGF-1 129.1 (39.7) 132.0 (39.9) 2.9 (21.1) .19
IGFBP-3 2,076.1 (441.5) 2,055.2 (426.2) -20.9 (167.7) .56
Estradiol 14.6 (5.2) 16.5 (9.7) 1.9 (9.0) .19
SHBG 50.2 (24.7) 51.8 (25.0) 1.7 (6.5) .08
c-peptide 4.6 (2.7) 4.6 (2.4) .04 (2.0) .55
Insulin 11.9 (11.6) 10.6 (7.0) 8.6 (.11) .60

IGF-1 is insulin-like growth factor.

IGFBP-3 is insulin-like growth factor binding protein.

SHGB is sex hormone binding globulin.

One woman was excluded because of a late follow-up, and nine women were lost to follow-up.

Difference is calculated as Week 12 - Week 2.

§

P-values were calculated using exact Wilcoxon signed rank tests (nonparametric mean pairwise tests).